Sample management at the test facility or clinical site, including sample collection an processing, is a critical aspect of regulated bioanalysis. This is reinforced in the FDA's final industry guidance on Bioanalytical Method Validation (BMV). For meaningful data, every effort should be made to ensure that the analytes' concentration is maintained, from sample collection to completion of bioanalysis.
|